ClinicalTrials.gov record
Completed Phase 2 Interventional

The Effect of Alendronate, Calcium, and Vitamin D on Bone Mineral Density in HIV Infected Patients

ClinicalTrials.gov ID: NCT00061256

Public ClinicalTrials.gov record NCT00061256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:09 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Once-Weekly Alendronate in HIV-Infected Subjects With Decreased Bone Mineral Density Receiving Calcium and Vitamin D

Study identification

NCT ID
NCT00061256
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
80 participants

Conditions and interventions

Conditions

Interventions

  • Alendronate Drug
  • Calcium carbonate Drug
  • Vitamin D Drug

Drug

Eligibility (public fields only)

Age range
25 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Aug 31, 2006
Last update posted
Aug 6, 2009

Ends 2006

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
20
Facility City State ZIP Site status
University of Alabama-Birmingham Birmingham Alabama 35294-2050
UCLA School of Medicine Los Angeles California 90095-1793
University of California, San Diego San Diego California 92103
San Francisco General Hospital San Francisco California 94110
Stanford Univ Stanford California 94305-5107
Georgetown University Medical Center Washington D.C. District of Columbia 20007
Northwestern University Chicago Illinois 60611-5012
Cook County Hospital Core Center Chicago Illinois 60612
Indiana Univ Hosp Indianapolis Indiana 46202-5250
Methodist Hosp of Indiana Indianapolis Indiana 46202-5250
Wishard Hosp Indianapolis Indiana 46202
Univ of Minnesota Minneapolis Minnesota 55455-0392
Nebraska Health System Omaha Nebraska 68198-5130
Chelsea Clinic New York New York 10011
NYU/Bellevue New York New York 10016-6481
AIDS Community Health Center Rochester New York 14642-0001
Univ of Rochester Med Ctr Rochester New York 14642-0001
Univ of North Carolina Chapel Hill North Carolina 27514
Case Western Reserve Univ Cleveland Ohio 44106-5083
MetroHealth Medical Center Cleveland Ohio 44109-1998
Ohio State University Columbus Ohio 43210
University of Pennsylvania, Philadelphia Philadelphia Pennsylvania 19104
Rhode Island Hosp Providence Rhode Island 02906
Stanley Street Treatment and Resource Providence Rhode Island 02906
The Miriam Hosp Providence Rhode Island 02906
Comprehensive Care Clinic Nashville Tennessee 37203
Univ of Texas, Galveston Galveston Texas 77555-0435
University of Washington (Seattle) Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00061256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 6, 2009 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00061256 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →